Femasys Inc/ US31447E1055 /
| 2024-04-18 9:59:30 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.31USD | - | 2,172 Turnover: 2,838.89 |
-Bid Size: - | -Ask Size: - | 1.34 | 1.28 |
GlobeNewswire
04-18
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the C...
GlobeNewswire
03-28
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
GlobeNewswire
03-21
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Tr...
GlobeNewswire
03-20
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Tre...
GlobeNewswire
03-13
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, ...
GlobeNewswire
03-06
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility...
GlobeNewswire
02-28
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as...
GlobeNewswire
02-06
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Ch...
GlobeNewswire
01-26
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovatio...
GlobeNewswire
01-23
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recog...
GlobeNewswire
2023-11-30
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
GlobeNewswire
2023-11-28
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
GlobeNewswire
2023-11-15
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte...
GlobeNewswire
2023-11-14
Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides...
GlobeNewswire
2023-10-25
Femasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women’s Health at the Americ...
GlobeNewswire
2023-10-04
Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medi...
GlobeNewswire
2023-09-27
Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate
GlobeNewswire
2023-09-25
Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Sol...
GlobeNewswire
2023-09-20
Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth...
GlobeNewswire
2023-09-06
Femasys to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2023-08-31
Femasys Inc. Obtains Medical Device Establishment License from Health Canada
